Role of renal sympathetic denervation in a refractory arterial hypertension patient;Papel de la denervación simpática de arterias renales en un paciente con hipertensión arterial refractaria

Nefrologia

Volumn 32, Issue 5, 2012, Pages 670-673

  Martínez Esteban, M Dolores ^a   Aranda Lara, Pedro ^a   Muñoz, Joaquín ^a   Toledo Rojas, Remedios ^a   Sola Moyano, Eugenia ^a   Torres Rueda, Álvaro ^a   Hernández Marrero, Domingo ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Refractory arterial hypertension; Renal sympathetic denervation

Indexed keywords

ARTICLE; CASE REPORT; DRUG RESISTANCE; HUMAN; HYPERTENSION; INNERVATION; KIDNEY; MALE; MIDDLE AGED; SYMPATHECTOMY;

DRUG RESISTANCE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; SYMPATHECTOMY;

EID: 84868254613     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Jul.11573     Document Type: Article

References (10)

1. Erdine S, Arslan E, Coca A, Resistant Hypertension. European Society Hypertension. Scientific Newsletter. Updated on Hypertension Management 2011;12(15):27-8.
2. Schmieder RE, Redon J, Grassi G, Kjeldsen S, Mancia G, Narkiewicz K, et al. ESH Position Paper: renal denervation- an interventional therapy of resistant hypertension. J Hypertens 2012;30(5):837-41.
3. Aranda-Lara P, Martínez-Esteban MD, Muñoz JJ, Hernández-Marrero. Denervación simpática de arterias renales: una nueva estrategia terapéutica en el manejo de la hipertensión arterial refractaria. Nefrologia 2012;32(5):555-7.
4. De la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, et al. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 2012;30:1211-6.
5. Schaid MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009;54:1195-201.
6. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009;54:690-7.
7. Simplicity HTN-1 Investigators 2011. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction to 24 months. Hypertension 2011;57:911-7.
8. Simplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlai MP, Schmieder RF, et al. Renal sympathetic denervation in patients with treatment resistant hypertension (The Simplicity TH-2 trial): a randomized control trial. Lancet 2010;376:1903-9.
9. Pietzsch JB, Geisler B, Esler M. Efficacy and clinical and economic effectiviness in resistant hypertensive subgroups. J Am Coll Cardiol 2012;59:E1716.
10. Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, et al. Monitorización ambulatoria de la presión arterial (MAPA): características clínicas de 31.530 pacientes. Med Clin (Barc) 2007;129(1):1-5.